All stock lists
Tevogen Inc. (NASDAQ:TVGN)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
6.46-0.07 (-1.00%)
Insider Score
––Not scored
TVGN Insider Score
Insiders here have filed 7 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
TVGN Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 60.14 K | 59.05 K | 85.79 K | 0.00 | 0.00 | 0.00 |
| Gross Profit | -60.14 K | -59.05 K | -85.79 K | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 2.38 M | 2.27 M | 2.50 M | 2.62 M | 2.74 M | 7.16 M |
| R&D Expense | 3.28 M | 3.13 M | 2.11 M | 3.11 M | 2.70 M | 3.20 M |
| Operating Expenses | 5.60 M | 5.34 M | 4.52 M | 5.73 M | 5.44 M | 10.36 M |
| Operating Income | -5.66 M | -5.40 M | -4.61 M | -5.73 M | -5.44 M | -10.36 M |
| Pretax Income | -5.76 M | -5.45 M | -4.68 M | -5.73 M | -5.50 M | -10.37 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -5.76 M | -5.45 M | -4.68 M | -5.73 M | -5.50 M | -10.37 M |
| EPS (Basic) | -1.52 | -1.61 | -1.20 | -1.50 | -1.53 | -3.25 |
| EPS (Diluted) | -1.52 | -1.61 | -1.20 | -1.50 | -1.53 | -3.25 |
| Shares Outstanding | 3.83 M | 3.49 M | 3.32 M | 3.92 M | 3.69 M | 3.23 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.